CDK7 Antikörper (C-Term)
Kurzübersicht für CDK7 Antikörper (C-Term) (ABIN1977641)
Target
Alle CDK7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Region between residues 300 and the C-terminus (residue 346) of human Cyclin-Dependent Kinase 7 using the numbering given in Swiss-Prot entry P50613 (GeneID 1022).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IP, PLA (1:1000 - 1:20000), WB (1:1000 - 1:15000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
-
Andere Bezeichnung
- CDK7
-
Hintergrund
-
Name/Gene ID: CDK7
Subfamily: CDC2/CDK
Family: Protein Kinase
Synonyms: CDK7, 39 kDa protein kinase, CDK-activating kinase, CDK-activating kinase 1, CDKN7, Cell division protein kinase 7, Cyclin-dependent kinase 7, HCAK, Protein kinase, Mpk-7, Serine/threonine kinase stk1, CAK, CAK1, Crk4, Kinase subunit of CAK, MO15, p39 Mo15, p39MO15, STK1 -
Gen-ID
- 1022
-
Pathways
- Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase
Target
-